<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00288587</url>
  </required_header>
  <id_info>
    <org_study_id>CP0007</org_study_id>
    <nct_id>NCT00288587</nct_id>
  </id_info>
  <brief_title>Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)</brief_title>
  <official_title>CP0007: Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NxStage Medical</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NxStage Medical</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the ability of Ultrafiltration to influence the rate
      of hemodynamic improvement, as measured by the decline in the pulmonary artery occlusion
      pressure, in patients with NYHA class III/IV Heart Failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be preformed in a specialized heart failure unit at the Cleveland Clinic
      Foundation (CCF) and will include both the UF-treated group and a control group receiving
      usual and customary care. Patients will be stratified according to renal function at the time
      of admission. Therapies will be guided by specific hemodynamic criteria routinely used at the
      study institution.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Required for the Pulmonary Artery Occlusion Pressure (PAOP) to be Maintained at a Value of Less Than or Equal to 18 mmHg for at Least Four Consecutive Hours (+/- 30 Minutes) During the Intervention Period.</measure>
    <time_frame>4 consecutive hours (+/- 30 minutes)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Discharge From the Heart Failure (HF) Unit, and Time to Discharge From the Hospital.</measure>
    <time_frame>Time from admission to endpoint achievement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Volume Removal During the Intervention Period</measure>
    <time_frame>Intervention start to end.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume Removal Rate.</measure>
    <time_frame>Intervention start to end.</time_frame>
    <description>Hours of therapy required to remove 1 liter of fluid normalized to body weight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Endpoint of Hospital Readmissions, Emergency Department Visits, and Deaths</measure>
    <time_frame>Hospital discharge to 90 days after discharge</time_frame>
    <description>Number of patients experiencing at least one of the composite endpoint measures within 90 days of hospital discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Heart Failure</condition>
  <condition>CHF</condition>
  <arm_group>
    <arm_group_label>Ultrafiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual &amp; Customary</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with conventional diuretic therapy upon hospital admission for treatment of decompensated heart failure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV loop diuretic</intervention_name>
    <description>Use of conventional diuretic therapy upon hospital admission for treatment of decompensated heart failure.</description>
    <arm_group_label>Usual &amp; Customary</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NxStage System One</intervention_name>
    <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
    <arm_group_label>Ultrafiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to Heart Failure Unit (H-22) with NYHA class III/IV HF and pulmonary artery
             catheter in situ

          -  Left ventricular ejection fraction &lt;40%

          -  Mean Pulmonary Artery Occlusion Pressure â‰¥20 mm Hg

          -  Able to give informed consent

        Exclusion Criteria:

          -  Currently on renal replacement therapy or determined to need renal replacement therapy
             at the time of enrollment

          -  Estimated glomerular filtration rate (GFR) &lt;15 mL/min

          -  Systolic blood pressure (SBP) &lt;80 mm Hg

          -  Acute coronary syndrome

          -  Hematocrit &gt;50%

          -  Malignancy other than prostrate or skin

          -  Chronic edematous states other than HF, including nephritic syndrome and cirrhosis

          -  Chronic inflammatory or infectious condition

          -  Pregnancy

          -  Previous enrollment in this study

          -  Expectation of need for heart transplantation or cardiac assist device within one week

          -  Pulmonary failure requiring intubation and mechanical ventilation

          -  Known or suspected hypersensitivity to dialysis membranes

          -  Severe aortic stenosis or regurgitation

          -  Severe mitral stenosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Hull, MD</last_name>
    <role>Study Director</role>
    <affiliation>NxStage Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hanna MA, Tang WH, Teo BW, O'Neill JO, Weinstein DM, Lau SM, Van Lente F, Starling RC, Paganini EP, Taylor DO. Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congest Heart Fail. 2012 Jan-Feb;18(1):54-63. doi: 10.1111/j.1751-7133.2011.00231.x. Epub 2011 Jul 20.</citation>
    <PMID>22277179</PMID>
  </results_reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2006</study_first_posted>
  <results_first_submitted>May 16, 2012</results_first_submitted>
  <results_first_submitted_qc>May 16, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 19, 2012</results_first_posted>
  <last_update_submitted>May 16, 2012</last_update_submitted>
  <last_update_submitted_qc>May 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>CHF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diuretics</mesh_term>
    <mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrafiltration</title>
          <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
        </group>
        <group group_id="P2">
          <title>Usual &amp; Customary Care</title>
          <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transplant</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Severe Aortic Stenosis</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrafiltration</title>
          <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
        </group>
        <group group_id="B2">
          <title>Usual &amp; Customary Care</title>
          <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="9.1"/>
                    <measurement group_id="B2" value="59" spread="15.5"/>
                    <measurement group_id="B3" value="59.5" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glomerular Filtration Rate (GFR)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>GFR &gt;50 mL/min/1.73m2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GFR &lt;50 mL/min/1.73m2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Required for the Pulmonary Artery Occlusion Pressure (PAOP) to be Maintained at a Value of Less Than or Equal to 18 mmHg for at Least Four Consecutive Hours (+/- 30 Minutes) During the Intervention Period.</title>
        <time_frame>4 consecutive hours (+/- 30 minutes)</time_frame>
        <population>Analysis was performed on the intent-to-treat group which consisted of all patients enrolled in this study.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrafiltration</title>
            <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
          </group>
          <group group_id="O2">
            <title>Usual &amp; Customary Care</title>
            <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Required for the Pulmonary Artery Occlusion Pressure (PAOP) to be Maintained at a Value of Less Than or Equal to 18 mmHg for at Least Four Consecutive Hours (+/- 30 Minutes) During the Intervention Period.</title>
          <population>Analysis was performed on the intent-to-treat group which consisted of all patients enrolled in this study.</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="4.2"/>
                    <measurement group_id="O2" value="34.8" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Discharge From the Heart Failure (HF) Unit, and Time to Discharge From the Hospital.</title>
        <time_frame>Time from admission to endpoint achievement</time_frame>
        <population>The analysis population was the intent-to-treat group, represented by all patients enrolled in this study.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrafiltration</title>
            <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
          </group>
          <group group_id="O2">
            <title>Usual &amp; Customary Care</title>
            <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Discharge From the Heart Failure (HF) Unit, and Time to Discharge From the Hospital.</title>
          <population>The analysis population was the intent-to-treat group, represented by all patients enrolled in this study.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time to discharge from HF unit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.63" spread="2.11"/>
                    <measurement group_id="O2" value="3.56" spread="1.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time to discharge from hospital</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.98" spread="4.81"/>
                    <measurement group_id="O2" value="18.93" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Volume Removal During the Intervention Period</title>
        <time_frame>Intervention start to end.</time_frame>
        <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrafiltration</title>
            <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
          </group>
          <group group_id="O2">
            <title>Usual &amp; Customary Care</title>
            <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Volume Removal During the Intervention Period</title>
          <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
          <units>milliliters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5215" spread="3406"/>
                    <measurement group_id="O2" value="2167" spread="2380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume Removal Rate.</title>
        <description>Hours of therapy required to remove 1 liter of fluid normalized to body weight.</description>
        <time_frame>Intervention start to end.</time_frame>
        <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrafiltration</title>
            <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
          </group>
          <group group_id="O2">
            <title>Usual &amp; Customary Care</title>
            <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Volume Removal Rate.</title>
          <description>Hours of therapy required to remove 1 liter of fluid normalized to body weight.</description>
          <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
          <units>milliliters/hour/kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="2.6"/>
                    <measurement group_id="O2" value="0.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Endpoint of Hospital Readmissions, Emergency Department Visits, and Deaths</title>
        <description>Number of patients experiencing at least one of the composite endpoint measures within 90 days of hospital discharge.</description>
        <time_frame>Hospital discharge to 90 days after discharge</time_frame>
        <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrafiltration</title>
            <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
          </group>
          <group group_id="O2">
            <title>Usual &amp; Customary Care</title>
            <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Endpoint of Hospital Readmissions, Emergency Department Visits, and Deaths</title>
          <description>Number of patients experiencing at least one of the composite endpoint measures within 90 days of hospital discharge.</description>
          <population>The analysis population is the intent-to-treat group which includes all patients enrolled on the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ultrafiltration</title>
          <description>Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.</description>
        </group>
        <group group_id="E2">
          <title>Usual &amp; Customary Care</title>
          <description>Patients treated with conventional diuretic therapy upon hospital admission for the treatment of decompensated heart failure.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Death (Cardiac reason)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Death (Infection-related)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Brady Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Worsening Heart Failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemic Episode</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Cramping</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Fever &gt; 37.3 C</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="19"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="18" subjects_affected="10" subjects_at_risk="19"/>
                <counts group_id="E2" events="11" subjects_affected="7" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotensive Episode</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Worsening Renal Failure</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="19"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Painful Access</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Leighann Cesar, RN</name_or_title>
      <organization>Cleveland Clinic Foundation</organization>
      <phone>216-445-6551</phone>
      <email>cesar1@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

